Royal Bank Of Canada Abbott Laboratories Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Abbott Laboratories stock. As of the latest transaction made, Royal Bank Of Canada holds 7,169,799 shares of ABT stock, worth $939 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,169,799

Previous 7,352,427 2.48%

Holding current value

$939 Million

Previous $832 Million 14.36%

% of portfolio

0.21%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $20.3 Million - $25.6 Million	-182,628 Reduced 2.48%	7,169,799 $951 Million
Q4 2024 Feb 14, 2025	BUY	$111.93 - $119.39 $2.63 Million - $2.8 Million	23,458 Added 0.32%	7,352,427 $832 Million
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $29.2 Million - $34.5 Million	291,928 Added 4.15%	7,328,969 $836 Million
Q2 2024 Nov 06, 2024	SELL	$100.73 - $112.44 $1.78 Million - $1.99 Million	-17,707 Reduced 0.25%	7,037,041 $731 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $20.3 Million - $22.7 Million	201,480 Added 2.94%	7,054,748 $733 Million
Q1 2024 Nov 05, 2024	SELL	$109.52 - $120.96 $24.1 Million - $26.6 Million	-220,124 Reduced 3.12%	6,834,624 $777 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $57.2 Million - $63.2 Million	522,286 Added 8.25%	6,853,268 $779 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $107 Million - $131 Million	1,182,094 Added 22.96%	6,330,982 $697 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $13.2 Million - $15.8 Million	-137,836 Reduced 2.61%	5,148,888 $499 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $67.8 Million - $75.5 Million	-672,504 Reduced 11.29%	5,286,724 $576 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $99.7 Million - $117 Million	-1,028,972 Reduced 14.72%	5,959,228 $603 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $83.3 Million - $97.7 Million	876,089 Added 14.33%	6,988,200 $767 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $35.4 Million - $41 Million	-365,965 Reduced 5.65%	6,112,111 $591 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $9.82 Million - $11.9 Million	-96,205 Reduced 1.46%	6,478,076 $704 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $51.8 Million - $63.1 Million	-454,147 Reduced 6.46%	6,574,281 $778 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $63.9 Million - $78.2 Million	552,956 Added 8.54%	7,028,428 $989 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $26.3 Million - $29.1 Million	-225,715 Reduced 3.37%	6,475,472 $765 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $709 Million - $834 Million	6,701,187 New	6,701,187 $777 Million

Others Institutions Holding ABT

# of Institutions

3,580

Shares Held

1.39B

Call Options Held

9.32M

Put Options Held

8.78M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Abbott Laboratories Transaction History